SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing a massive sell-off as a weak revenue outlook and significant declines in the China market overshadow an earnings beat, fueling intense debate over whether this decade-long low represents a generational buying opportunity or a deeper structural decline. The community is sharply divided, with many traders betting on a sharp V-shaped recovery and a "juicy" dividend, while skeptics argue that the brand's long-term growth is dead and are cautioning against catching a falling knife.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

Restoration Hardware is experiencing high volatility as investors react to mixed quarterly earnings and the companys ongoing struggles with trade tariffs and a challenging housing market. While the community remains deeply divided, with many debating whether the stock is a long-term value opportunity or a failing luxury retailer, the stock continues to see significant short interest and intense speculation regarding future legal developments surrounding trade policy.

SharonAI Holdings, Inc. engages in providing high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure technologies. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is trending following the announcement of a massive multi-year AI infrastructure contract, with the community actively speculating that its low float could trigger a significant short squeeze. Traders are closely monitoring the stock's price action and volume levels for signs of a parabolic move, while debating whether the current market valuation fully reflects the scale of the new partnership.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is currently experiencing significant market attention as traders monitor potential short squeeze setups driven by high short interest and anticipation of institutional moves. The conversation is heavily focused on the stock's consolidation patterns near key support levels, with participants debating the impact of upcoming earnings, potential turnaround catalysts, and the influence of major investors on the stock's future trajectory.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing heightened retail interest as traders monitor its history of volatile, low-float runs and speculate on the potential for a short squeeze. Community discussion is heavily focused on the stock's lack of available shares to borrow, extreme cost-to-borrow fees, and comparisons to previous multi-bagger rallies, with many debating whether this represents a genuine reversal or a potential liquidity trap.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop is facing significant selling pressure as investors grapple with shifting consumer sentiment and broader market volatility, with community discussions split between long-term growth optimism and concerns regarding current valuation levels. The stock is currently under a microscope as market participants debate whether these lows present a buying opportunity or a warning sign of further downward consolidation.

Mega Fortune Co., Ltd. operates as a holding company which provides information technology services. It specializes in delivering comprehensive IoT solutions and services across various industries. The firm offers low carbon property management, energy, stock and GreenTech management services. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

Mega Fortune is trending as investors debate its potential for volatile, high-percentage swings characteristic of low-float Chinese IPOs, drawing comparisons to previous market runners. While some traders are aggressively positioning for a rapid squeeze fueled by lock-up dynamics, many participants are cautioning others about the significant risks associated with its history of extreme volatility and pump-and-dump patterns.

Tema ETF Trust - Tema Space Innovators ETF

Investors are actively debating the launch of the Tema Space Innovators ETF (NASA), which has captured attention for its targeted exposure to the private space sector, including SpaceX, ahead of a highly anticipated potential IPO. While many in the community are comparing it to other space-focused funds and discussing its low liquidity and AUM, bullish sentiment is building around its role as a dedicated vehicle for institutional-quality access to the modern space economy.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is facing significant volatility as investors weigh the company's long-term potential in quantum annealing against broader market fears, recession risks, and aggressive competitive pressure from IBM's recent advancements. While bulls highlight D-Wave's dual-platform strategy, growing bookings, and strategic government partnerships, the community remains divided, with skeptics pointing to high dilution, lack of profitability, and the stock's recent steep correction as signs of a struggling speculative play.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as the community closely monitors the company's progress on scaling its proprietary hydrometallurgical facility in Bolivia and its upcoming implementation in Idaho. Investors are actively discussing the potential impact of this technology on processing critical minerals, alongside speculation regarding anticipated Department of Defense shipments and the broader strategic necessity of domestic supply chains for antimony and tungsten.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nisa Investment Advisors LLC Has $156 Million Stock Position in AbbVie Inc. $ABBV

Nisa Investment Advisors LLC increased its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 42.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 682,721 shares of the company's stock after purchasing...

Meyer Handelman Co. Boosts Stock Holdings in AbbVie Inc. $ABBV

Meyer Handelman Co. lifted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 3.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange...

Moody Lynn & Lieberson LLC Has $43.98 Million Holdings in AbbVie Inc. $ABBV

Moody Lynn & Lieberson LLC increased its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 4.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 192,463...

AbbVie Inc. $ABBV Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC reduced its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 28.0% during the 4th quarter, according to the company in its most recent filing with the...

AbbVie (NYSE:ABBV) Shares Up 2% - Time to Buy?

AbbVie (NYSE:ABBV) Trading 2% Higher - Time to Buy...

Pharmaceutical Stocks To Watch Today - March 31st

Apellis Pharmaceuticals, Centessa Pharmaceuticals, Eli Lilly and Company, AbbVie, Pfizer, Abbott Laboratories, and Novo Nordisk A/S are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that r...

Medical Stocks To Add to Your Watchlist - March 31st

Apellis Pharmaceuticals, Centessa Pharmaceuticals, Eli Lilly and Company, UnitedHealth Group, Boston Scientific, AbbVie, and Pfizer are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of companies involved in healthcare including p...

ANIP Stock Outlook: Cortrophin Growth vs. Retina Reset

ANI Pharmaceuticals' growth pivots to Cortrophin Gel as retina headwinds weigh on 2025, with 2026 recovery hopes hinging on specialty momentum and portfolio reset.

Is ANIP Undervalued? How to Read Its 9.3x Forward P/E

ANI Pharmaceuticals trades at just 9.3x forward earnings, far below peers - raising a key question: is this a bargain or a signal of execution risks ahead?

ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease

ANIP eyes 2026 pivot as Rare Disease targets 60% of sales, with Cortrophin growth, gout sales force expansion, and retina rebound shaping momentum.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

Current Price	$214.60
Prev Close	$217.49
Open	$218.42
Dividend Yield	2.91%
50-Day Moving Average	$221.73
Beta	0.32
Avg. Volume	7.25M
PE Ratio	92.10

52-Week High	$244.81
52-Week Low	$164.39
Market Capitalization	$384.56B
EPS (Annual)	$2.36
Price to Book	-117.58
Revenue Per Employee	$1.07M

ABBV
Abbvie Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABBV News

ABBVAbbvie Inc